Cash Being Raised and on Hand SALES OF EQUITY S
Post# of 86
Posted On: 12/19/2014 11:34:12 AM
Cash Being Raised and on Hand
SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
In January 2014, the Company sold an aggregate of 107,708 shares of the Company’s common stock and warrants to purchase 64,627 shares of the Company’s common stock for aggregate gross cash proceeds of $229,114. The warrants are exercisable for cash at an exercise price of $3.67 per share expiring five years from the date of issuance.
In April 2014, the Company sold an aggregate of 229,760 shares of the Company’s common stock and warrants to purchase 137,856 shares of the Company’s common stock for aggregate gross cash proceeds of $229,114. The warrants are exercisable for cash at an exercise price of $3.75 per share expiring five years from the date of issuance.
In August 2014, the Company sold an aggregate of 225,200 shares of the Company’s common stock and warrants to purchase 135,120 shares of the Company’s common stock for aggregate gross cash proceeds of $471,215. The warrants are exercisable for cash at an exercise price of $2.75 per share expiring five years from the date of issuance.
In September 2014, the Company sold an aggregate of 156,000 shares of the Company’s common stock and warrants to purchase 93,600 shares of the Company’s common stock for aggregate gross cash proceeds of $333,029. The warrants are exercisable for cash at an exercise price of $3.75 per share expiring five years from the date of issuance.
SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
In January 2014, the Company sold an aggregate of 107,708 shares of the Company’s common stock and warrants to purchase 64,627 shares of the Company’s common stock for aggregate gross cash proceeds of $229,114. The warrants are exercisable for cash at an exercise price of $3.67 per share expiring five years from the date of issuance.
In April 2014, the Company sold an aggregate of 229,760 shares of the Company’s common stock and warrants to purchase 137,856 shares of the Company’s common stock for aggregate gross cash proceeds of $229,114. The warrants are exercisable for cash at an exercise price of $3.75 per share expiring five years from the date of issuance.
In August 2014, the Company sold an aggregate of 225,200 shares of the Company’s common stock and warrants to purchase 135,120 shares of the Company’s common stock for aggregate gross cash proceeds of $471,215. The warrants are exercisable for cash at an exercise price of $2.75 per share expiring five years from the date of issuance.
In September 2014, the Company sold an aggregate of 156,000 shares of the Company’s common stock and warrants to purchase 93,600 shares of the Company’s common stock for aggregate gross cash proceeds of $333,029. The warrants are exercisable for cash at an exercise price of $3.75 per share expiring five years from the date of issuance.
(0)
(0)BioSig Technologies Inc. (BSGM) Stock Research Links
Scroll down for more posts ▼